This scientist heavy plant sciences team just brought on board a CEO that can take it out of the lab (note: they are not saying that, while at the same time… they’re kinda saying that!)
This crucial study is for FDA approval, and CEO Andrew Barnell tells bizblip that making sure key demographic groups are well represented in this cohort is vital in proving the company technology.